Graft-Versus-Host Disease

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-319-03218-4_36
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.

  2016cited by this paper
• How we treat chronic graft-versus-host disease.

  2015cited by this paper
• Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

  2014cited by this paper
• HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

  2014cited by this paper
• Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.

  2013cited by this paper
• Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.

  2013influential reference
• The role of nutrition and effects on the cytokine milieu in allogeneic hematopoietic stem cell transplantation.

  2012cited by this paper
• A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease.

  2012influential reference
• Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha.

  2011cited by this paper
• Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

  2011cited by this paper
• Vitamin A Deficiency Impairs Vaccine-Elicited Gastrointestinal Immunity

  2011cited by this paper
• New perspectives on the biology of acute GVHD

  2010cited by this paper
• Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.

  2008cited by this paper
• Vitamin effects on the immune system: vitamins A and D take centre stage

  2008cited by this paper
• Graft-versus-host disease

  2007cited by this paper
• IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract.

  2007cited by this paper
• Immunobiology of allogeneic hematopoietic stem cell transplantation.

  2007cited by this paper
• An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues

  2006cited by this paper
• Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

  2006cited by this paper
• National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

  2005cited by this paper
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

  2005cited by this paper
• Effects of Vitamin A Supplementation on Immune Responses and Correlation with Clinical Outcomes

  2005cited by this paper
• In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets.

  2005cited by this paper
• Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation

  2005cited by this paper
• Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human α/β T cell receptor

  2005cited by this paper
• In vivo imaging of graft-versus-host-disease in mice.

  2004cited by this paper
• Vitamin A deficiency increases the in vivo development of IL-10-positive Th2 cells and decreases development of Th1 cells in mice.

  2004cited by this paper
• Acute graft-versus-host disease does not require alloantigen expression on host epithelium

  2002cited by this paper
• Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease.

  2002cited by this paper
• APCs in the Liver and Spleen Recruit Activated Allogeneic CD8+ T Cells to Elicit Hepatic Graft-Versus-Host Disease1

  2002cited by this paper
• High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice.

  2000cited by this paper
• Prevention of graft versus host disease by inactivation of host antigen-presenting cells.

  1999cited by this paper
• Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.

  1998cited by this paper
• CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.

  1997cited by this paper
• [Interleukin-2 receptor].

  1997cited by this paper
• Enhanced graft-versus-host disease in older recipient mice following allogeneic bone marrow transplantation

  1997cited by this paper
• Use of stem cells from mismatched related donors

  1997cited by this paper
• Vitamin A deficiency results in a priming environment conducive for Th1 cell development

  1995cited by this paper
• Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease.

  1995cited by this paper
• Prognostic factors for long‐term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graftversus‐host disease

  1994cited by this paper
• In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function.

  1994influential reference
• CD4+ T CELLS, BUT NOT CD8+ T CELLS, MEDIATE THE BREAKING OF TOLERANCE IN MIXED ALLOGENEIC CHIMERAS (B10 + B10.BR ± B10)

  1993cited by this paper
• STUDIES OF THE USE OF L‐LEUCYL‐L‐LEUCINE METHYL ESTER IN CANINE ALLOGENEIC MARROW TRANSPLANTATION

  1993cited by this paper
• Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation.

  1993cited by this paper
• Prevention of acute lethal graft-versus-host disease in F1 hybrid mice by pretreatment of the graft with anti-NK-1.1 and complement.

  1992cited by this paper
• In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.

  1992cited by this paper
• Rapamycin suppression of host-versus-graft and graft-versus-host disease in MHC-mismatched rats.

  1992cited by this paper
• Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease.

  1992cited by this paper
• Cyclosporine A and peripheral tolerance. Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes.

  1992cited by this paper
• T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission.

  1992cited by this paper
• Improved survival from potentially lethal graft‐vs.‐host disease by donor pretreatment with a recipient‐specific blood transfusion. I. Requirements for induction and specificity of the effect

  1992cited by this paper
• A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo.

  1992cited by this paper
• Antilymphocytic antibodies and marrow transplantation. XII. Suppression of graft-versus-host disease by T-cell-modulating and depleting antimouse CD3 antibody is most effective when preinjected in the marrow recipient.

  1992cited by this paper
• RS-61443 prevents graft-versus-host disease but not rejection in allogeneic rat small bowel transplants.

  1992cited by this paper
• Graft-versus-host disease in children receiving HLA-identical allogeneic bone marrow transplants with a low adjusted T lymphocyte dose.

  1991cited by this paper
• B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

  1991cited by this paper
• Hematopoietic reconstitution and prevention of graft-versus-host disease with UVB-irradiated haploidentical murine spleen and marrow cells.

  1991cited by this paper
• Immunological unresponsiveness by deoxyspergualin therapy in mice undergoing lethal graft-vs-host disease, and successful adoptive transfer of unresponsiveness.

  1991cited by this paper
• Deoxyspergualin in lethal murine graft-versus-host disease.

  1991cited by this paper
• Vascularized bone marrow transplantation (VBMT): induction of stable mixed T-cell chimerism and transplantation tolerance in unmodified recipients.

  1991cited by this paper
• Immunologic tolerance to renal allografts after bone marrow transplants from the same donors.

  1991cited by this paper
• Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

  1991cited by this paper
• Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506.

  1991cited by this paper
• REDUCTION IN THE SEVERITY OF GRAFT‐VERSUS-HOST DISEASE AND INCREASED SURVIVAL IN ALLOGENEIC MICE BY TREATMENT WITH MONOCLONAL ANTIBODIES TO CELL ADHESION ANTIGENS LFA‐lα AND MALA‐2

  1991cited by this paper
• Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3.

  1991cited by this paper
• In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443.

  1991cited by this paper
• CD3+ T cells in severe combined immunodeficiency (scid) mice. IV. Graft‐vs. ‐host resistance of H‐2d scid mice to intravenous injection of allogeneic H‐2b (C57BL/6) spleen cells

  1991cited by this paper
• Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients.

  1991cited by this paper
• The host/donor origin of cells mediating NK and NK-like cytotoxic activity in F1 hybrid mice with acute graft-versus-host reactions.

  1991cited by this paper
• Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies.

  1991cited by this paper
• A subpopulation of asialo GM1-positive cells plays a protective role in the occurrence of graft-versus-host disease (GVHD) in mice.

  1991cited by this paper
• Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.

  1991cited by this paper
• A cell culture model for T lymphocyte clonal anergy.

  1990cited by this paper
• Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial.

  1990cited by this paper
• Enrichment of natural suppressor activity in a wheat germ agglutinin positive hematopoietic progenitor-enriched fraction of monkey bone marrow.

  1990cited by this paper
• Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

  1990cited by this paper
• Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?

  1990cited by this paper
• Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: transfused class I MHC- incompatible splenocytes veto clonal responses of antigen-reactive Lyt- 2+ T cells

  1990cited by this paper
• Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.

  1990cited by this paper
• Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation.

  1990cited by this paper
• Self-nonself discrimination by T cells.

  1990cited by this paper
• Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease.

  1990cited by this paper
• A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation.

  1990cited by this paper
• The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.

  1990cited by this paper
• Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.

  1990cited by this paper
• Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation.

  1990cited by this paper
• Allogeneic thymus transplantation as a means to induce transplantation tolerance.

  1990cited by this paper
• The staphylococcal enterotoxins and their relatives.

  1990cited by this paper
• In vitro comparison of two methods of T cell depletion associated with different rates of graft failure after allogeneic marrow transplantation.

  1990cited by this paper
• Ultraviolet B-induced loss of HLA class II antigen expression on lymphocytes is dose, time, and locus dependent.

  1990cited by this paper
• Ex vivo spermine dialdehyde treatment prevents lethal GVHD in a murine bone marrow transplantation model.

  1990cited by this paper
• Use of an immunoglobulin preparation enriched for IgM (Pentaglobin) for the treatment of acute graft-versus-host disease.

  1990cited by this paper
• Cellular Mechanisms in Neonatal and Adult Tolerance

  1989cited by this paper
• Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants.

  1989cited by this paper
• Inhibition by deoxyspergualin of allo-reactive cytotoxic activity in mouse graft-versus-host disease.

  1989cited by this paper
• Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.

  1989cited by this paper
• Enhancement of thyroid allograft survival following organ culture. Alteration of tissue immunogenicity.

  1989cited by this paper
• Use of trimetrexate for the prevention of graft-versus-host disease.

  1989cited by this paper
• Idiotypic Regulation of T Cells in Graft‐Versus‐Host Disease and Autoimmunity

  1989cited by this paper
• Suppression of second set rejection of skin allografts by donor bone marrow cells.

  1989cited by this paper

• Роль CLA+T-клеток в развитии кожных заболеваний

  2018cites this paper
• Membranous nephropathy succeeding autologous hematopoietic stem cell transplant: a case report

  2018cites this paper
• Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

  2017cites this paper
• Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response

  2017cites this paper
• Non-transferrin-bound iron in hematopoietic stem cell transplantation

  2015influential citation
• Allogeneic stem cell transplantation : patients’ and sibling donors’ perspectives

  2015cites this paper
• In vitro characterisation and expansion of human regulatory T cells for their in vivo application in the induction of tolerance in haematopoietic stem cell and solid organ transplantation

  2015cites this paper
• A safety and feasibility study with platelet lysate expanded bone marrow mesenchymal stromal cells for the treatment of acute graft-versus-host disease in Brazil

  2014cites this paper
• Nature Reviews UNCORRECTED PROOF

  2014cites this paper
• Endothelial dysfunction and altered mechanical and structural properties of resistance arteries in a murine model of graft-versus-host disease.

  2014cites this paper
• T cell Migration and Graft Versus Host Disease

  2014cites this paper
• Okuläre Oberfläche - nicht infektiös

  2014cites this paper
• Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD Prophylaxis

  2014cites this paper
• Novel T lymphocyte proliferation assessment using whole mouse cryo-imaging

  2014cites this paper
• Oral Combined Therapy with Probiotics and Alloantigen Induces B Cell–Dependent Long-Lasting Specific Tolerance

  2014cites this paper
• Allogene periphere Blutstammzelltransplantation nach dosisreduzierter Konditionierung bei Patienten mit akuter myeloischer Leukämie abhängig von zytogenetischen und molekulargenetischen Aberrationen

  2014cites this paper
• A question of persistence: Langerhans cells and graft-versus-host disease

  2014cites this paper
• Dental Pulp Polyps Contain Stem Cells Comparable to the Normal Dental Pulps

  2014cites this paper
• Kinetics of IFN-γ and IL-17 Production by CD4 and CD8 T Cells during Acute Graft-versus-Host Disease

  2014cites this paper
• Targeting the IL17 pathway for the prevention of graft-versus-host disease.

  2014cites this paper
• Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors

  2014cites this paper
• Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients

  2014cites this paper
• Membranous nephropathy as a manifestation of graft-versus-host disease: association with HLA antigen typing, phospholipase A2 receptor, and C4d.

  2014cites this paper
• Molekulargenetische Analyse der minor Histokompatibilitäts-Antigene (mHag) und deren Relevanz für die allogene Blutstammzell-Transplantation

  2014cites this paper
• Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.

  2014cites this paper
• Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD.

  2014cites this paper
• The Role of Dendritic Cells in Graft-Versus-Tumor Effect

  2014cites this paper
• Cholestasis in the Hospitalized Patient

  2014cites this paper
• This information is current as Persistence of Graft-Versus-Host Disease Infiltrating Donor CD8+ T Cells and Parenchymal Cells Leads to Expansion of Loss of B7-H1 Expression by Recipient

  2013cites this paper
• Effect on Survival. A Quantitative Analysis in 1,402 Patients Incidence and −− Acute Bleeding After Bone Marrow Transplantation (BMT)

  2013cites this paper
• Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease.

  2013cites this paper
• transplantation hematopoietic stem cell transplantation compared with bone marrow mobilized peripheral blood - granulocyte colony-stimulating factor Increased presence of anti-HLA antibodies early after allogeneic

  2013cites this paper
• MicroRNAs: The Missing Link in the Biology of Graft-Versus-Host Disease?

  2013cites this paper
• Stem cell source-dependent reconstitution of FOXP3+ T cells after pediatric SCT and the association with allo-reactive disease

  2013cites this paper
• Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.

  2013cites this paper
• Steroid refractory psoriasiform cutaneous graft versus host disease successfully treated by extracorporeal photopheresis: a case report.

  2013influential citation
• Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.

  2013cites this paper
• T-cell dose peripheral blood hematopoietic cell transplantation is affected by CD8+ Engraftment and survival following reduced-intensity allogeneic

  2013cites this paper
• Dual Receptor T Cells Mediate Pathologic Alloreactivity in Patients with Acute Graft-Versus-Host Disease

  2013cites this paper
• The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease.

  2013cites this paper
• Characteristics of chronic GVHD after cord blood transplantation

  2013cites this paper
• by cyclosporin A -chain signaling and inhibited γ induced by common cytokine receptor Cell-surface trafficking and release of flt3 ligand from T lymphocytes is

  2013cites this paper
• hematopoietic cell transplantation for Gram-negative bacteremia and mortality after allogeneic Lipopolysaccharide binding protein promoter variants influence the risk

  2013cites this paper
• Immunosuppressive properties of Wharton's jelly derived mesenchymal stromal cells in the treatment of graft versus host disease in rat model

  2013cites this paper
• moiety of the T-cell receptor chain Fv fusion immunotoxin specifically targeting the CD3 epsilon Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single-

  2013cites this paper
• IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation

  2013cites this paper
• Establishing a target exposure for once-daily intravenous busulfan given with fludarabine and thymoglobulin before allogeneic transplantation.

  2013cites this paper
• induction by effector memory T cells A repertoire-independent and cell intrinsic defect in murine GVHD

  2013cites this paper
• The expression of Th17-associated cytokines in human acute graft-versus-host disease.

  2013cites this paper
• Nutritional components regulate the gut immune system and its association with intestinal immune disease development

  2013cites this paper
• The Role of NK Cells and T Cells in the Rejection of Embryonic Stem Cell-Derived Tissues

  2013cites this paper
• Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change.

  2013cites this paper
• Notch signaling in hematopoietic cell transplantation and T cell alloimmunity.

  2013cites this paper
• Preimplantation factor reduces graft-versus-host disease by regulating immune response and lowering oxidative stress (murine model).

  2013cites this paper
• Ocular manifestations of graft-versus-host disease.

  2013cites this paper
• CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT.

  2013cites this paper
• Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients

  2013cites this paper
• peripheral blood from HLA-identical siblings failure after allogeneic transplantation of CD34+ selected cells from The number of donor CD3+ cells is the most important factor for graft

  2013cites this paper
• The impact of morphological and immunohistological changes in minor salivary glands on the health of the oral cavity in HSCT patients

  2013cites this paper
• transplantation continuous bortezomib administration after allogeneic bone marrow Differential effects of donor T-cell cytokines on outcome with

  2013cites this paper
• comparing cyclosporine plus prednisone versus prednisone alone Therapy for chronic graft-versus-host disease: a randomized trial

  2013cites this paper
• total body irradiation for relapsed and refractory mantle cell lymphoma Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy

  2013cites this paper
• malignancies nonmyeloablative conditioning for patients with hematologic HLA-matched unrelated donor hematopoietic cell transplantation after

  2013cites this paper
• Graft-versus-Host Disease Is Enhanced by Selective CD73 Blockade in Mice

  2013cites this paper
• efficiency by positron emission tomography mapping of disease activity, prediction and monitoring of treatment Clinical molecular imaging in intestinal graft-versus-host disease:

  2013cites this paper
• Comparison between ultra-performance liquid chromatography with tandem mass spectrometry and a chemiluminescence immunoassay in the determination of cyclosporin A and tacrolimus levels in whole blood

  2013cites this paper
• disease induction by naive and memory phenotype CD4 T cells Effects of donor T-cell trafficking and priming site on graft-versus-host

  2013cites this paper
• Apoptotic cells in allogeneic hematopoietic stem cell transplantations: “turning trash into gold”

  2012cites this paper
• K12/SECTM1, an interferon‐γ regulated molecule, synergizes with CD28 to costimulate human T cell proliferation

  2012cites this paper
• Endothelial and epithelial barriers in graft-versus-host disease.

  2012cites this paper
• Allogeneic Transplantation of Hematopoietic Stem Cells

  2012cites this paper
• Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease.

  2012cites this paper
• Oral cryotherapy can significantly reduce oral mucositis but not acute GVHD incidence in Flu/Mel conditioning allo-SCT

  2012cites this paper
• Decreased Levels of Circulating IL17-Producing CD161+CCR6+ T Cells Are Associated with Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

  2012cites this paper
• Occurrence and Impact of Minor Histocompatibility Antigens' Disparities on Outcomes of Hematopoietic Stem Cell Transplantation from HLA-Matched Sibling Donors

  2012cites this paper
• UTILIDAD DE LA CÁPSULA ENDOSCÓPICA DE INTESTINO DELGADO EN LA ENFERMEDAD DE INJERTO CONTRA HUÉSPED (EICH)

  2012cites this paper
• Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17.

  2012cites this paper
• Early allo-SCT for AML with a complex aberrant karyotype—results from a prospective pilot study

  2012cites this paper
• Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study

  2012cites this paper
• Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens.

  2012cites this paper
• The effectiveness of tacrolimus and minidose methotrexate in the prevention of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in children: a single-center study in Korea

  2012cites this paper
• Halofugine prevents cutaneous graft versus host disease by suppression of Th17 differentiation

  2012cites this paper
• Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses

  2012cites this paper
• Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation.

  2012cites this paper
• inducible regulatory T-cell generation during GVHD + and CD8 + and IL-2 receptors in CD4 β Cell-autonomous role of TGF

  2012cites this paper
• Graft Vasculopathy in Clinical Hand Transplantation

  2012cites this paper
• BCSH/BSBMT Guideline: Diagnosis and Management of Chronic Graft- versus-Host Disease

  2012cites this paper
• Intestinal Graft-Versus-Host Disease

  2012cites this paper
• Haploidentical/mismatched hematopoietic stem cell transplantation without in vitro T cell depletion for T cell acute lymphoblastic leukemia.

  2012cites this paper
• EFFECTS OF MYCOPHENOLATE MOFETIL AND CYCLOSPORIN A ON CORD BLOOD AND PERIPHERAL BLOOD NATURAL KILLER CELLS

  2012cites this paper
• CD8+ Foxp3+ Regulatory T Cells Are Induced during Graft-versus-Host Disease and Mitigate Disease Severity

  2012cites this paper
• Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.

  2012cites this paper
• Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndromes.

  2012cites this paper
• Exploiting the Bioenergetics of Disease-Causing Lymphocytes for Selective Immunomodulation.

  2012cites this paper
• Prophylactic effects of interleukin-2 receptor antagonists against graft-versus-host disease following unrelated donor peripheral blood stem cell transplantation.

  2012cites this paper
• Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies: a retrospective analysis

  2012cites this paper
• Novel regulatory therapies for prevention of Graft-versus-host disease

  2012cites this paper
• Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation

  2011cites this paper
• Treatment of graft-versus-host-disease with mesenchymal stromal cells.

  2011cites this paper
• Alloimmune Response Results in Expansion of Autoreactive Donor CD4+ T Cells in Transplants That Can Mediate Chronic Graft-versus-Host Disease

  2011cites this paper